Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
DarioHealth Corp(DRIO)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for DRIO
10/23/2026: DRIO (1-star) is currently NOT-A-BUY. Pass it for now.
DarioHealth is a health technology firm that provides an integrated, multi-condition digital health platform for managing chronic diseases like diabetes and hypertension. Its primary business strength lies in its unified platform architecture, which allows it to serve employers and health plans with a single point of entry. The company’s main growth opportunity centers on capturing more enterprise customers by bundling various health services, such as MSK and behavioral health. However, investors must monitor significant risks, including persistent operating losses, stiff competition from better-capitalized incumbents, and execution challenges. This stock is best suited for growth-oriented investors with a high risk tolerance who are looking to monitor the company’s ability to achieve sustainable profitability.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers high-growth potential in the digital health space but comes with substantial execution and cash-burn risks. |
| Momentum investor | Weak fit | Momentum fit is conditional on a positive price upturn and strong volume, which has not been consistently present for this stock. |
| Value investor | Weak fit | The lack of consistent profitability and negative earnings makes this stock unsuitable for traditional value-based investment strategies. |
| Dividend investor | Weak fit | DarioHealth does not pay a dividend and focuses entirely on capital reinvestment. |
| Low-risk investor | Weak fit | High volatility and inherent business-model risks make this stock inappropriate for low-risk portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock's beta and history of price swings indicate significant market risk for investors. |
| Valuation risk | High | High dependence on future growth expectations makes the stock susceptible to valuation compression. |
| Competition risk (Digital Health & AI) | High | Intense pressure from larger, better-funded incumbents threatens market share and pricing power. |
| Business quality | Medium | While the platform technology is scalable, the business model is still proving its path to self-sustaining profitability. |
| Dividend income | Low / none | The company provides no income stream to shareholders. |
| Execution risk | Medium / high | Success depends on the company's ability to integrate acquisitions and sign large, long-term enterprise contracts. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Highly Choppy
The stock has experienced frequent, large price swings that make its near-term movement less predictable.
Analysis of Past Performance
Type Stock | Historic Profit -65.72% | Avg. Invested days 16 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/23/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 36.94M USD | Price to earnings Ratio - | 1Y Target Price 13.6 |
Price to earnings Ratio - | 1Y Target Price 13.6 | ||
Volume (30-day avg) 39.6K shares | Beta 1.18 | 52 Weeks Range 3.01 - 16.44 | Updated Date 10/24/2026 |
52 Weeks Range 3.01 - 16.44 | Updated Date 10/24/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.28 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| B2B2C Digital Health | Subscriptions sold to employers and health plans for employee/member access to the Dario platform. | This is the primary growth engine; success depends on winning big corporate and insurance contracts. |
| Consumer Direct | Sales of glucose meters, blood pressure cuffs, and related supplies directly to individual users. | This provides a steady revenue stream and serves as a funnel for long-term customer engagement. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE - | Forward PE 10.59 | Enterprise Value 84.89M | Price to Sales(TTM) 1.76 |
Enterprise Value 84.89M | Price to Sales(TTM) 1.76 | ||
Enterprise Value to Revenue 4.04 | Enterprise Value to EBITDA -0.59 | Shares Outstanding 9.80M | Shares Floating 6.91M |
Shares Outstanding 9.80M | Shares Floating 6.91M | ||
Percent Insiders 21.65 | Percent Institutions 9.11 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.